Our Neurology panel provides a high-throughput, multiplex immunoassay enabling analysis of 92 neurology-related protein biomarkers across 96 samples simultaneously. This high level of multiplexing is achieved without any compromise on data quality, thanks to our proprietary Proximity Extension Assay (PEA) technology.
The panel panel offers a mix of established markers related to neurobiological processes and neurological diseases (e.g. neural development, axon guidance, synaptic function, or specific conditions such as Alzheimer’s disease), as well as some more exploratory proteins with broader roles in processes such as cellular regulation, immunology, development and metabolism. This balanced selection provides an ideal basis for protein biomarker discovery in the neurology area. For optimal assay performance, each analyte in the panel has been assessed in terms of sample material, specificity, precision, sensitivity, dynamic range, matrix effects and interference. Of the 92 assays provided, 89 are new and unique to this panel, with just 3 biomarkers overlapping with other Olink panels.
The panel is available via fee-for-service analysis, or as a reagent kit (requires a Fludigm® Biomark qPCR instrument to run).